StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.5
Power Rank trend -> Rising
06/13/2025 16:00:00 EST
TransMedics Group Inc (TMDX)
Industry: Medical Devices
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, TMDX has been trading in a range between $140.86 and $121.31 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
TMDX is breaking above top of the recent 20 day range at $140.86 and appears that it could have some more upside. If it enters a yellow zone the trend may be faltering - consider exiting or taking profits. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
TransMedics Group Inc $TMDX entered a Green zone 46 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $121.1429, a potential down side of -15.21% from the recent price of 142.88. The stock is trading 24.14% (potential upside) below its 52 week high of $177.37 and 159.78 % (potential downside) above its 52 week low of $55.00 - based on the recent price.
Company Summary
TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
News
| These 24 Stocks Are Ripe for a Short Squeeze With the way negative stock market sentiment has piled up recently, short squeezes have generated some massive returns. Source: Schaeffers Research Thu, 12 Jun 2025 15:11:17 -0400 Sentiment: Neutral |
| Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMDX. Source: Accesswire Thu, 12 Jun 2025 10:00:00 -0400 Sentiment: Neutral |
| Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May In May, three stocks that released earnings stood out due to their massive sales beats. These names are mid-cap companies with market capitalizations between $2 billion and $10 billion. Source: MarketBeat Thu, 12 Jun 2025 07:53:59 -0400 Sentiment: Positive |
| Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law Firm NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of TransMedics Group, Inc. (NASDAQ: TMDX) breached their fiduciary duties to shareholders. Source: GlobeNewsWire Tue, 10 Jun 2025 10:39:00 -0400 Sentiment: Neutral |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMDX. Source: Accesswire Tue, 10 Jun 2025 10:00:00 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 177.37 52 Week Low: 55 Beta: 2.076 50 Day MA: 107.1241 200 Day MA: 96.4663 Earnings / Revenue Trends Qtr Earnings Growth YOY: 1.006 Qtr Revenue Growth YOY: 0.482 Forward PE: 77.5194 Trailing PE: 101.3333